NuVasive
ProfileJobs

NuVasive

Suggest Edit
    • Healthbiotechmedical devicesplatform
    NuVasive is a medical device company focused on developing minimally disruptive surgical products and procedurally integrated solutions for the spine. Its principal product offering is based on its Maximum Access Surgery, or MAS platform. The MAS platform combines several categories of solutions that collectively minimize soft tissue disruption during spine surgery with maximum visualization and safe, easy reproducibility for the surgeon: a proprietary software-driven nerve avoidance system and intra-operative monitoring support; MaXcess, a unique split-blade retractor system; a wide variety of specialized implants; and several biologic products to aid in the spinal fusion process. MAS significantly reduces surgery time and returns patients to activities of daily living much faster than conventional approaches. 
    Revenue(FY, 2017)
    $1 B
    Market capitalization(2018-04-20)
    $2.9 B
    Type
    Public
    HQ
    San Diego, US
    Founded
    1997
    Size (employees)
    2,300 (est)+5%
    Website
    nuvasive.com
    NuVasive was founded in 1997 and is headquartered in San Diego, US
    Report incorrect company information

    NuVasive Office Locations

    NuVasive has offices in Singapore, Memphis, Columbia, San Diego and in 9 other locations
    San Diego, US (HQ)
    7475 Lusk Blvd
    Aliso Viejo, US
    100 101 Enterprise
    Columbia, US
    250 10420 Little Patuxent Pkwy
    Fairborn, US
    1 Herald Square
    Memphis, US
    101 4670 E Shelby Dr
    Kew, AU
    620 High St
    Show all (13)
    Report incorrect company information

    NuVasive Financials and Metrics

    NuVasive Financials

    NuVasive's revenue was reported to be $1.03 b in FY, 2017
    USD

    Revenue (FY, 2017)

    		1 b

    Gross profit (FY, 2017)

    		760.5 m

    Gross profit margin (FY, 2017), %

    		73.9%

    Net income (FY, 2017)

    		81.3 m

    Market capitalization (20-Apr-2018)

    		2.9 b

    Cash (31-Dec-2017)

    		72.8 m
    NuVasive's current market capitalization is $2.9 b.
    Annual
    USDFY, 2013Y, 2014Y, 2015FY, 2016FY, 2017

    Revenue

    		685.2 m762.4 m811.1 m962.1 m1 b

    Revenue growth, %

    		11%6%19%

    Cost of goods sold

    		180.5 m182.4 m194.5 m240.1 m269 m

    Gross profit

    		504.7 m580.1 m616.6 m722 m760.5 m
    Quarterly
    USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

    Revenue

    		192.4 m202.9 m200.5 m215 b236.2 m239.6 m249.9 m260.6 m247.4 m

    Cost of goods sold

    		45.7 m48.4 m49.2 m54.2 b59.7 m59.2 m61.6 m66.4 m65.6 m

    Gross profit

    		146.7 m154.5 m151.4 m160.8 b176.5 m180.5 m188.3 m194.2 m181.8 m

    Gross profit Margin, %

    		76%76%75%75%75%75%75%75%73%
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Cash

    		102.8 m142.4 m192.3 m153.6 m72.8 m

    Accounts Receivable

    Inventories

    		10.9 m21.6 m8.8 m208.2 m247.2 m

    Current Assets

    		536 m705.9 m702.8 m575.4 m559 m
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

    Cash

    		100.6 m110.8 m106.5 m130.7 m88.5 m78.6 m141.3 m270.1 m263.1 m203.8 m134 m130.9 m62.2 m

    Accounts Receivable

    		96.2 m

    Inventories

    		140.7 m147.7 m157.4 m159.7 m163.4 m163.7 m164.9 m200.7 m201.9 m212.8 m223.1 m236.8 m249 m

    Current Assets

    		488 m606.3 m587.1 m629.6 m632.9 m684.3 m698.5 m692.2 m712 m616.9 m563.3 m592.2 m529.9 m
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Net Income

    		7 m(17.5 m)65.3 m35.4 m81.3 m

    Depreciation and Amortization

    		63.1 m65.8 m65.9 m42 m121.2 m

    Inventories

    		(3.6 m)(5.2 m)1.2 m(22.6 m)(35.3 m)

    Accounts Payable

    		(5.6 m)
    Quarterly
    USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

    Net Income

    		31.4 m41.4 m54.2 m(9.3 m)26 m29.5 m12.3 m24.6 m57.7 m

    Depreciation and Amortization

    		16.1 m32.6 m49 m21.2 m46.3 m73.8 m29.5 m58.7 m88.9 m

    Inventories

    		157.4 m159.7 m(11.4 m)(15.2 m)(19.8 m)(9.4 m)(12 m)(22.4 m)(13.6 m)(29 m)(36.2 m)

    Cash From Operating Activities

    		26 m35.2 m48 m57.4 m100.2 m96 m28 m67.1 m118.9 m
    show all
    USDY, 2017

    Revenue/Employee

    		468 k

    Financial Leverage

    		2.1 x
    Show all financial metrics

    NuVasive Acquisitions / Subsidiaries

    Acquired CompanyDateDeal Size
    SafePassage December 12, 2017
    Biotronic NeuroNetwork June 06, 2016$98 m
    Ellipse Technologies January 05, 2016$410 m
    Report incorrect company information

    Competitors

    Zimmer Biomet
    Health - Public
    Stryker
    Health - Public
    Synchron
    Health - Private
    Aira.io
    Health - Private
    Compare competitors

    NuVasive News and Updates

    January 31, 2018

    Sports Medicine Market: Positive Long -Term Growth Outlook 2016 – 2024

    Growing activity in sports and athletic activity among young population is the major factor driving growth of the global sports medicine market. Posted via Industry Today. Follow us on Twitter @IndustryToday
    January 16, 2018

    Biological Implants 2018 Global Market Key Players - Integra LifeSciences Corporation, Edwards LifeSciences Corporation, NuVasive, Inc,

    Wiseguyreports.Com Adds “Biological Implants – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2025” To Its Research Database. Posted via Industry Today. Follow us on Twitter @IndustryToday
    December 18, 2017

    Cervical Total Disc Replacement Device Market is Expected to be worth US$ 1,750.1 Mn by 2021

    Revenue contribution by CTDR device market to the global total disc replacement market is expected to increase to US$ 1,750.1 by the end of 2021, expanding at a CAGR of 23.1% during 2015–2021. Posted via Industry Today. Follow us on Twitter @IndustryToday
    December 18, 2017

    Growing Industry of Intraoperative Neurophysiological Monitoring Market: Globally is Estimated to Reach 1.1 Billion With ~8.9% CAGR by 2027

    Intraoperative Neurophysiological Monitoring Market Information, by type (EEG, EMG, Evoked Potential (EP)) by Method (Invasive, Non-Invasive, Minimally Invasive) by Source (In-house, Outsource, Tele-Health), by Procedure – Global Forecast to 2027 Posted via Industry Today. Follow us on Twitter @Indu…
    December 14, 2017

    Spinal Fusion Market Projected to Register 5.4% CAGR through 2017-2027

    Future Market Insights has announced the addition of the “Spinal Fusion Market: Global Industry Analysis and Opportunity Assessment 2017 - 2027" report to their offering. Posted via Industry Today. Follow us on Twitter @IndustryToday
    October 10, 2017

    World Artificial Disc Replacement Market is Growing at a CAGR of 15 % During Forecasted Period 2017-2023

    Market Research Future published a half-cooked research report on global artificial disc replacement market, Global Artificial Disc Replacement Market Is Growing At A CAGR Of 15 % During Forecasted Period 2017-2023 Posted via Industry Today. Follow us on Twitter @IndustryToday
    Report incorrect company information
    Download PDF